Germany | Bayern

Zurück zur Suche

Internationale Partnersuche

Innovation & Technologie Anfrage

Small molecule hit and lead compounds for most indications

Country of Origin: United Kingdom
Reference Number: TRUK20170714003
Publication Date: 14 July 2017

Summary

An international chemistry contract research organisation has built an extensive skillset in synthetic and medicinal chemistry. They are looking for new hit and lead compounds that they could advance into a robust clinical candidate, with desired properties agreed upon in advance. They would share in the eventual commercial return but not the IP. There is little limit in terms of indication areas. Drug discovery businesses & research groups are sought for joint ventures or technical cooperation.

Description

An international chemistry contract research organisation has built an extensive skillset in synthetic and medicinal chemistry. At the same time, they have built a good customer base in the Pharma industry. The company has identified 5 robust candidates for clinical trials for their clients over the past 3 years.

They are interested in early stage small compounds that would benefit from optimisation or synthesis as a chemical or medicinal chemistry project. The idea is to explore dual contribution/dual return type projects. The parties will agree on a goal in terms of the desired potency etc that would be attractive for the Pharma industry. The chemistry company would contribute significantly towards the development of a robust compound with the agreed attributes and later share any commercial returns. At the same time they will not make any claims on the IP generated.
The company has worked in practically all indication areas so that is not a limitation. They would also consider a grant-funded project. Mostly, joint ventures and technical cooperation are sought around early stage small compounds. First, desired technical and commercial goals will be set followed by a detailed description of the involvement of either party.

Expertise sought

What is sought is promising hit and lead compounds that are currently sub-optimal, with regards to their selectivity or specificity, or availability.

Stage Of Development

Available for demonstration

Requested partner

Type of partner sought: industry and academia;
- Type of activity of the partner: drug discovery and optimisation;
- Task to be performed by the partner sought: to provide non-confidential information on high priority projects and the type of collaboration envisaged. Mostly, joint ventures and technical cooperation are sought around early stage small compounds. First, desired technical and commercial goals will be set followed by a detailed description of the involvement of either party.

Kooperationsanfrage stellen